Advertisement
Screener

QUIDELORTHO CORP (QDEL) Number of Reportable Segments

2.8 / 5 stars · 68/120 Roast Me

QUIDELORTHO CORP Number of Reportable Segments

QUIDELORTHO CORP (QDEL) reported Number of Reportable Segments of 5 Reportable_segment for the 6-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.

Financial Statements › Notes › Segment Reporting

us-gaap:NumberOfReportableSegments · last filed 2026-08-07

  • QUIDELORTHO CORP number of reportable segments for the quarter ending 2024-03-31 was 3.00 segment.
  • QUIDELORTHO CORP number of reportable segments for fiscal 2023 was 3.00 segment.

segment

Period endNumber of Reportable Segments 3 monthNumber of Reportable Segments 6 monthNumber of Reportable Segments 9 monthNumber of Reportable Segments 12 month
2024-09-293.00 segment
10-Q · filed 2024-11-08
2024-06-303.00 segment
10-Q · filed 2024-08-01
2024-03-313.00 segment
10-Q · filed 2024-05-09
2023-01-013.00 segment
10-K · filed 2023-02-23
2022-10-023.00 segment
10-Q · filed 2022-11-04
2022-07-033.00 segment
10-Q · filed 2022-08-05

Reportable_segment

Period endNumber of Reportable Segments 3 monthNumber of Reportable Segments 6 monthNumber of Reportable Segments 12 month
2026-06-285.00 Reportable_segment
10-Q · filed 2026-08-07
2026-03-295.00 Reportable_segment
10-Q · filed 2026-05-06
2025-12-285.00 Reportable_segment
10-K · filed 2026-02-19
2024-12-293.00 Reportable_segment
10-K · filed 2025-02-27
2023-12-313.00 Reportable_segment
10-K/A · filed 2024-08-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92